By deploying mobile These new initiatives build on the Company’s longstanding commitment to address HIV through a broad portfolio of transformational medicines and combination therapies; history of novel programs and partnerships to increase access to HIV medicines and care; collaborative research on innovative tools and treatments; strategic philanthropy partnerships that have resulted in significant gains in the elimination of mother-tochild transmission of HIV; and issue advocacy at high-level forums and with leading stakeholders in the fight against HIV.